DocSym
β
Searchsearch
Search
(N05.7) Unspecified nephritic syndrome : diffuse crescentic glomerulonephritis
More details coming soon
207 118 in individuals diagnosis unspecified nephritic syndrome : diffuse crescentic glomerulonephritis confirmed
9 250 deaths with diagnosis unspecified nephritic syndrome : diffuse crescentic glomerulonephritis
5% mortality rate associated with the disease unspecified nephritic syndrome : diffuse crescentic glomerulonephritis
Diagnosis unspecified nephritic syndrome : diffuse crescentic glomerulonephritis is diagnosed Men are 8.80% more likely than Women
112 677
Men receive the diagnosis unspecified nephritic syndrome : diffuse crescentic glomerulonephritis
5 145 (4.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
94 441
Women receive the diagnosis unspecified nephritic syndrome : diffuse crescentic glomerulonephritis
4 105 (4.3 %)Died from this diagnosis.
Risk Group for the Disease unspecified nephritic syndrome : diffuse crescentic glomerulonephritis - Men aged 55-59 and Women aged 25-29
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 0-1, 95+
In Women diagnosis is most often set at age 0-94
Disease Features unspecified nephritic syndrome : diffuse crescentic glomerulonephritis
Absence or low individual and public risk
Unspecified nephritic syndrome : diffuse crescentic glomerulonephritis - what does this mean
Unspecified nephritic syndrome is a type of glomerulonephritis caused by an immune response that causes inflammation in the glomeruli, the tiny filters in the kidney. this inflammation leads to the formation of crescents, or crescentic glomerulonephritis, which can cause protein and red blood cells to leak into the urine and cause kidney damage.
What happens during the disease - unspecified nephritic syndrome : diffuse crescentic glomerulonephritis
More details coming soon
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count (CBC)
- Urinalysis
- Serum creatinine and blood urea nitrogen (BUN) levels
- Serum electrolyte levels
- Kidney biopsy
- Imaging studies, such as ultrasound or CT scan
- Antinuclear antibody (ANA) test
- Cytomegalovirus (CMV) antibody test
- Kidney function tests
- Renal angiography
Treatment and Medical Assistance
Main goal of the treatment: Reduce inflammation and prevent damage to the kidneys.
- Administer corticosteroid medications to reduce inflammation.
- Prescribe immunosuppressive drugs to suppress the immune system.
- Monitor kidney function with regular blood and urine tests.
- Provide dietary advice and guidance to reduce the workload on the kidneys.
- Encourage a healthy lifestyle, with regular exercise and plenty of rest.
- Educate the patient and family about the disease and its progression.
- Provide emotional support and counseling.
- Refer the patient to a nephrologist for specialized care.
15 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Unspecified nephritic syndrome : diffuse crescentic glomerulonephritis - Prevention
Prevention of unspecified nephritic syndrome and diffuse crescentic glomerulonephritis is best achieved by maintaining a healthy lifestyle, including eating a balanced diet, exercising regularly, avoiding smoking, and managing any underlying health conditions such as high blood pressure or diabetes. vaccines may also be available to protect against certain infections that can cause nephritic syndrome. additionally, it is important to seek prompt medical attention for any signs or symptoms of kidney disease.